Skip to Main Content.
Site navigation
Fidelity.com Home
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log In
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log Out
  • Accounts & Trade
    • Portfolio Log In Required
    • Portfolio
    • AccountPositions Log In Required
    • AccountPositions
    • Trade Log In Required
    • Trade
    • Trading Dashboard Log In Required
    • Trading Dashboard Log In Required
    • Active Trader Pro
    • Transfers
    • Cash Management Log In Required
    • Cash Management
    • Bill Pay Log In Required
    • Bill Pay
    • Full View Log In Required
    • Full View
    • Security Settings Log In Required
    • Security Settings
    • Account Features Log In Required
    • Account Features
    • Statements Log In Required
    • Statements
    • Fidelity Alternative Investments Program Log In Required
    • Tax Forms & Information
    • Retirement Distributions Log In Required
    • Fidelity Rewards+registered trademark Log In Required
    • Fidelity Rewards+registered trademark Log In Required
    • New Account Checklist Log In Required
    • Lending Solutions-Line of Credit Log In Required
    • Refer a Friend
  • Planning & Advice
    • What We Offer
    • Build Your Plan
    • My Goals
    • Financial Basics
    • Building Savings
    • Robo Investing Plus Financial Advice
    • Wealth Management
    • Find an advisor
    • Retirement
    • Life Events
    • Saving & Investing for a Child
    • Charitable Giving
    • Philanthropic Consulting
  • News & Research
    • News
    • Wealth Management Insights
    • Watch List Log In Required
    • Quotes
    • Quotes
    • Alerts Log In Required
    • Mutual Funds
    • Stocks
    • Fixed Income, Bonds & CDs
    • ETFs
    • Options
    • Markets & Sectors
    • IPOs
    • Annuities
    • Learning Center
    • Notebook
    • Notebook
  • Investment Products
    • Mutual Funds
    • Retirement & IRAs
    • Stocks and Trading
    • Crypto
    • Direct Indexing
    • Fixed Income, Bonds & CDs
    • ETFs
    • Options
    • Sustainable Investing
    • Cash Management & Credit Cards
    • Managed Accounts
    • 529 College Savings
    • Health Savings Accounts
    • Annuities
    • Life Insurance & Long Term Care
  • Why Fidelity
    • The Fidelity Advantage
    • Planning & Advice
    • Trading
    • Straightforward Pricing
    • Insights & Tools
    • Security & Protection
    • Marketplace Solutions
    • About Fidelity
    • Careers
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log In
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log Out
Content and data provided by various third parties and Fidelity − Terms of Use
  • Research >
  • Stocks >
  • News & Events >

Stock Details


  • Snapshot
  • Detailed Quote
  • Advanced Chart &
    Technical Analysis Opens in New Window
  • News & Events
  • Compare
  • Analyst Opinions
  • Research Reports
  • Key Statistics
  • Earnings
  • Dividends
  • Ownership & Insiders
  • Financial Statements
  • SEC Filings

RELATED RESOURCES

  • Stock Research Overview
  • Stock Screeners
  • Markets & Sectors
  • Fidelity Learning Center Opens in New Window
Print Format
Change Text Size:
  • Default text sizeA
  • Larger text sizeA
  • Largest text sizeA

Earnings Scheduled For March 15, 2022

BY Benzinga
— 4:51 AM ET 03/15/2022

 

Companies Reporting Before The Bell

** IDEAYA Biosciences NASDAQ:IDYA is likely to report quarterly loss at $0.31 per share on revenue of $8.98 million.

** Citi Trends NASDAQ:CTRN is projected to report quarterly earnings at $1.12 per share on revenue of $250.54 million.

** Precision BioSciences NASDAQ:DTIL is likely to report quarterly loss at $0.47 per share on revenue of $7.75 million.

** SPX FLOW NYSE:FLOW is estimated to report quarterly loss at $0.17 per share on revenue of $10.88 million.

** Brickell Biotech NASDAQ:BBI is likely to report quarterly loss at $0.08 per share on revenue of $150.00 thousand.

** Imara NASDAQ:IMRA is expected to report earnings for its fourth quarter.

** Gamida Cell NASDAQ:GMDA is estimated to report earnings for its fourth quarter.

** Syros Pharmaceuticals NASDAQ:SYRS is likely to report quarterly loss at $0.47 per share on revenue of $4.80 million.

** Global X Guru Index ETF NYSE:GURU is likely to report quarterly loss at $0.16 per share on revenue of $6.75 million.

** ANI Pharmaceuticals NASDAQ:ANIP is estimated to report quarterly earnings at $0.74 per share on revenue of $56.30 million.

** Kandi Technologies Gr NASDAQ:KNDI is projected to report earnings for its fourth quarter.

** Athenex NASDAQ:ATNX is projected to report quarterly loss at $0.18 per share on revenue of $40.26 million.

** IT Tech Packaging AMEX:ITP is likely to report earnings for its fourth quarter.

** IHS Holding NYSE:IHS is estimated to report quarterly loss at $0.13 per share on revenue of $398.75 million.

** Sovos Brands NASDAQ:SOVO is expected to report quarterly earnings at $0.11 per share on revenue of $183.87 million.

** Sophia Genetics NASDAQ:SOPH is expected to report quarterly loss at $0.36 per share on revenue of $11.20 million.

** Dole NYSE:DOLE is likely to report quarterly earnings at $0.10 per share on revenue of $2.23 billion.

** Janus Intl Gr NYSE:JBI is estimated to report quarterly earnings at $0.08 per share on revenue of $213.75 million.

** Katapult Holdings NASDAQ:KPLT is expected to report quarterly loss at $0.06 per share on revenue of $72.18 million.

** FTC Solar NASDAQ:FTCI is projected to report quarterly loss at $0.13 per share on revenue of $72.58 million.

** Natural Resources NYSE:NRP is expected to report earnings for its fourth quarter.

** Kamada NASDAQ:KMDA is estimated to report quarterly earnings at $0.02 per share on revenue of $25.63 million.

** CooTek Cayman NYSE:CTK is expected to report quarterly loss at $0.01 per share on revenue of $49.60 million.

 

Companies Reporting After The Bell

** Aspen Group NASDAQ:ASPU is expected to report quarterly loss at $0.09 per share on revenue of $18.79 million.

** Bird Global NYSE:BRDS is projected to report quarterly loss at $0.34 per share on revenue of $50.78 million.

** HireQuest NASDAQ:HQI is likely to report quarterly earnings at $0.16 per share on revenue of $5.67 million.

** Opiant Pharmaceuticals NASDAQ:OPNT is expected to report quarterly loss at $0.01 per share on revenue of $13.26 million.

** LexinFintech Holdings NASDAQ:LX is projected to report earnings for its fourth quarter.

** Lument Finance Trust NYSE:LFT is projected to report quarterly earnings at $0.10 per share on revenue of $6.02 million.

** HyreCar NASDAQ:HYRE is expected to report quarterly loss at $0.27 per share on revenue of $10.32 million.

** Surgalign Holdings NASDAQ:SRGA is estimated to report quarterly loss at $0.11 per share on revenue of $20.71 million.

** GoHealth NASDAQ:GOCO is likely to report quarterly earnings at $0.15 per share on revenue of $527.64 million.

** Zedge AMEX:ZDGE is projected to report quarterly earnings at $0.15 per share on revenue of $6.21 million.

** Performant Financial NASDAQ:PFMT is projected to report quarterly loss at $0.02 per share on revenue of $29.81 million.

** Cherry Hill Mortgage NYSE:CHMI is estimated to report quarterly earnings at $0.28 per share on revenue of $6.22 million.

** Park-Ohio Hldgs NASDAQ:PKOH is projected to report quarterly loss at $0.12 per share on revenue of $364.23 million.

** Champions Oncology NASDAQ:CSBR is expected to report quarterly earnings at $0.02 per share on revenue of $12.47 million.

** JOYY NASDAQ:YY is estimated to report quarterly earnings at $0.36 per share on revenue of $652.43 million.

** Clipper Realty NYSE:CLPR is likely to report quarterly loss at $0.07 per share on revenue of $31.31 million.

** Seritage Growth Props NYSE:SRG is projected to report earnings for its fourth quarter.

** Eastman Kodak NYSE:KODK is projected to report earnings for its fourth quarter.

** Ryan Specialty Group NYSE:RYAN is expected to report quarterly earnings at $0.28 per share on revenue of $378.80 million.

** European Wax Center NASDAQ:EWCZ is estimated to report quarterly earnings at $0.11 per share on revenue of $44.76 million.

** Alpha Teknova NASDAQ:TKNO is projected to report quarterly loss at $0.17 per share on revenue of $8.44 million.

** SentinelOne NYSE:S is expected to report quarterly loss at $0.18 per share on revenue of $60.68 million.

** Markforged Holding NYSE:MKFG is likely to report quarterly loss at $0.08 per share on revenue of $24.51 million.

** Angel Oak Mortgage NYSE:AOMR is estimated to report quarterly earnings at $0.39 per share on revenue of $15.43 million.

** Talis Biomedical NASDAQ:TLIS is likely to report quarterly loss at $1.28 per share on revenue of $1.33 million.

** Volt Information Sciences AMEX:VOLT is expected to report quarterly loss at $0.13 per share on revenue of $225.50 million.

** Smartsheet NYSE:SMAR is estimated to report quarterly loss at $0.15 per share on revenue of $151.66 million.

** CarLotz NASDAQ:LOTZ is estimated to report quarterly loss at $0.15 per share on revenue of $72.95 million.

** Shift Technologies NASDAQ:SFT is likely to report quarterly loss at $0.61 per share on revenue of $185.86 million.

** Atlas Technical NASDAQ:ATCX is estimated to report quarterly earnings at $0.12 per share on revenue of $140.12 million.

** TRACON Pharmaceuticals NASDAQ:TCON is estimated to report quarterly loss at $0.35 per share on revenue of $60.00 thousand.

** Northwest Pipe NASDAQ:NWPX is projected to report quarterly earnings at $0.56 per share on revenue of $92.00 million.

** Athersys NASDAQ:ATHX is estimated to report quarterly loss at $0.07 per share on revenue of $40.00 thousand.

** Caleres NYSE:CAL is projected to report quarterly earnings at $0.67 per share on revenue of $677.21 million.

** FutureFuel NYSE:FF is likely to report earnings for its fourth quarter.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

More SYRS News

  • Syros Pharmaceuticals's Earnings: A Preview
    Benzinga - 11:03 AM ET 03/14/2022
  • The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
    Benzinga - 5:37 PM ET 03/13/2022
Fidelity Investments. Copyright 1998–2022 FMR LLC. 
All rights reserved. 

  • Terms of Use|
  • Privacy|
  • Security|
  • Site Map 
Close